Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:associated_with |
chronic diseases
|
| gptkbp:enhances |
acute phase response
|
| gptkbp:established |
apoptosis
|
| gptkbp:has_part |
gptkb:healthcare_organization
gptkb:Company autoimmune diseases obesity |
| gptkbp:has_role |
COVID-19 severity
|
| https://www.w3.org/2000/01/rdf-schema#label |
IL-6
|
| gptkbp:influences |
neurotransmitter release
|
| gptkbp:is_aimed_at |
therapeutic antibodies
|
| gptkbp:is_involved_in |
gptkb:historical_event
gptkb:psychologist anxiety cognitive decline fatigue metabolism aging cell differentiation cell proliferation cell signaling cellular stress response hypoxia immune response therapeutic interventions tumor growth allergic reactions chronic pain inflammation metabolic syndrome sleep disorders wound healing neuroinflammation stress response muscle regeneration cardiovascular diseases sepsis chronic kidney disease pain perception oxidative stress insulin resistance angiogenesis chronic inflammation tissue repair viral infections metastasis hormonal regulation bacterial infections neuroendocrine signaling bone metabolism muscle wasting metabolic adaptation immune evasion endothelial dysfunction immune checkpoint regulation fever response exercise response gut microbiota interaction |
| gptkbp:measures |
blood tests
|
| gptkbp:produced_by |
gptkb:T_cells
fibroblasts macrophages |
| gptkbp:regulates |
B cell differentiation
|
| gptkbp:bfsParent |
gptkb:T-helper_17_cells
gptkb:IL-17_family gptkb:inflammatory_myofibroblastic_tumor |
| gptkbp:bfsLayer |
6
|